Cargando…

Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review

Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease and is also associated with other harmful entities such as obesity, metabolic syndrome, dyslipidemia, and diabetes. NAFLD is a significant public health concern worldwide, impacting individuals of all ages, and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres-Peña, Jose D., Arenas-de Larriva, Antonio P., Alcala-Diaz, Juan F., Lopez-Miranda, Jose, Delgado-Lista, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058124/ https://www.ncbi.nlm.nih.gov/pubmed/36986213 http://dx.doi.org/10.3390/nu15061483

Ejemplares similares

Ceruloplasmin and Coronary Heart Disease—A Systematic Review
por: Arenas de Larriva, Antonio P., et al.
Publicado: (2020)

Influence of dietary intervention on microvascular endothelial function in coronary patients and atherothrombotic risk of recurrence
por: Millan-Orge, Marta, et al.
Publicado: (2021)

Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study
por: Martin-Piedra, Laura, et al.
Publicado: (2021)

Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients with Coronary Heart Disease: From the CORDIOPREV Study
por: Hidalgo-Moyano, Cristina, et al.
Publicado: (2022)

A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2022)

Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

Correction to: Long‑term effect of a dietary intervention with two‑healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study
por: de la Cruz-Ares, Silvia, et al.
Publicado: (2021)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2023)

Mediterranean Diet and Endothelial Function: A Review of its Effects at Different Vascular Bed Levels
por: Torres-Peña, Jose D., et al.
Publicado: (2020)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
por: Karbasi-Afshar, Reza, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023)

Coenzyme Q(10) and Cardiovascular Diseases
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2021)

Dietary patterns and risk of non-alcoholic fatty liver disease
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
por: Perdomo, Carolina M., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia
por: Rivera-Álvarez, Montserrat, et al.
Publicado: (2022)

Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
por: Torres, Jorge-Luis, et al.
Publicado: (2018)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
por: Brouwers, Martijn C. G. J., et al.
Publicado: (2019)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

Effects of anti-inflammatory dietary patterns on non-alcoholic fatty liver disease: a systematic literature review
por: Abdallah, Jayden, et al.
Publicado: (2023)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease
por: Dascalu, Daciana
Publicado: (2023)

Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
por: Hernandez-Rodas, Maria Catalina, et al.
Publicado: (2015)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
por: Lombardi, Rosa, et al.
Publicado: (2020)

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
por: Karaoğlan, Beliz Bahar, et al.
Publicado: (2023)

High-density lipoproteins and non-alcoholic fatty liver disease
por: Hoekstra, Menno, et al.
Publicado: (2023)

Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
por: Saenz, Marissa, et al.
Publicado: (2023)

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
por: Ismaiel, Abdulrahman, et al.
Publicado: (2019)

The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children
por: Di Sessa, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60hg12621aiakhtu02sdc8f31g